Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (91-100 of 284) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|October 1, 1995
Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvestP Auquier, G Macquart-Moulin, J P Moatti, et al.
Pathologie-Biologie|September 1, 1988
[Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis]G Michel, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Lancet (London, England)|July 25, 1987
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemiasD Maraninchi, E Gluckman, D Blaise, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Leukemia|April 22, 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparisonM Mohty, H de Lavallade, P Ladaique, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
Bone Marrow Transplantation|April 1, 1996
Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized studyC Faucher, A G Le Corroller, C Chabannon, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Pageof 29

Showing results (91-100 of 284) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|October 1, 1995
Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvestP Auquier, G Macquart-Moulin, J P Moatti, et al.
Pathologie-Biologie|September 1, 1988
[Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis]G Michel, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Lancet (London, England)|July 25, 1987
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemiasD Maraninchi, E Gluckman, D Blaise, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Leukemia|April 22, 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparisonM Mohty, H de Lavallade, P Ladaique, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
Bone Marrow Transplantation|April 1, 1996
Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized studyC Faucher, A G Le Corroller, C Chabannon, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Pageof 29